Across TCGA pan-cancer cohorts, LINC01476 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01476’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01476 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01476 is over-expressed in tumor.
KIRC are the cancer types where LINC01476 tumor–normal differential expression is most reproducible.